Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Optic atrophy 1 is an A-kinase anchoring protein on lipid droplets that mediates adrenergic control of lipolysis.

Pidoux G, Witczak O, Jarnæss E, Myrvold L, Urlaub H, Stokka AJ, Küntziger T, Taskén K.

EMBO J. 2011 Oct 7;30(21):4371-86. doi: 10.1038/emboj.2011.365.

2.

Splicing factor arginine/serine-rich 17A (SFRS17A) is an A-kinase anchoring protein that targets protein kinase A to splicing factor compartments.

Jarnaess E, Stokka AJ, Kvissel AK, Skålhegg BS, Torgersen KM, Scott JD, Carlson CR, Taskén K.

J Biol Chem. 2009 Dec 11;284(50):35154-64. doi: 10.1074/jbc.M109.056465. Epub 2009 Oct 19.

3.

Design of proteolytically stable RI-anchoring disruptor peptidomimetics for in vivo studies of anchored type I protein kinase A-mediated signalling.

Torheim EA, Jarnaess E, Lygren B, Taskén K.

Biochem J. 2009 Oct 23;424(1):69-78. doi: 10.1042/BJ20090933.

PMID:
19715558
4.

Dual specificity A-kinase anchoring proteins (AKAPs) contain an additional binding region that enhances targeting of protein kinase A type I.

Jarnaess E, Ruppelt A, Stokka AJ, Lygren B, Scott JD, Taskén K.

J Biol Chem. 2008 Nov 28;283(48):33708-18. doi: 10.1074/jbc.M804807200. Epub 2008 Sep 29.

5.

Spatiotemporal control of cAMP signalling processes by anchored signalling complexes.

Jarnaess E, Taskén K.

Biochem Soc Trans. 2007 Nov;35(Pt 5):931-7. Review.

PMID:
17956249

Supplemental Content

Loading ...
Support Center